Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systematic Review with Meta-Analysis: The Effects of Probiotics in Nonalcoholic Fatty Liver Disease
Meng-Wei Xiao, Shixin Lin, Zhaohua Shen, et al.
Gastroenterology Research and Practice (2019) Vol. 2019, pp. 1-19
Open Access | Times Cited: 69

Showing 26-50 of 69 citing articles:

The role of probiotic supplementation in inflammatory biomarkers in adults: an umbrella meta-analysis of randomized controlled trials
Amir Hossein Faghfouri, Ladan Gol Mohammad Pour Afrakoti, Zeynab Kavyani, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 5, pp. 2253-2268
Closed Access | Times Cited: 14
The effect of probiotic consumption on lipid profile, glycemic index, inflammatory markers, and liver function in NAFLD patients: A systematic review and meta-analysis of randomized controlled trials
Sadegh Mozaffari, Mahdeyeh Aliari, Solaleh Emamgholipour, et al.
Journal of Diabetes and its Complications (2024) Vol. 38, Iss. 8, pp. 108780-108780
Closed Access | Times Cited: 4
Probiotics for autism spectrum disorder: An updated systematic review and meta-analysis of effects on symptoms
Saman Soleimanpour, Mohammad Abavisani, Alireza Khoshrou, et al.
Journal of Psychiatric Research (2024) Vol. 179, pp. 92-104
Closed Access | Times Cited: 4
Gut microbiome in non-alcoholic fatty liver disease
Anastasios Mpountouridis, Christina Tsigalou, Ioanna Bezirtzoglou, et al.
Frontiers in Gastroenterology (2025) Vol. 3
Open Access
Therapeutic Strategies to Modulate Gut Microbial Health: Approaches for Chronic Metabolic Disorder Management
Mariangela Rondanelli, Sara Borromeo, Alessandro Cavioni, et al.
Metabolites (2025) Vol. 15, Iss. 2, pp. 127-127
Open Access
Probiotics as a Complementary Therapy for Management of Obesity: A Systematic Review
Salman Shirvani-Rad, Ozra Tabatabaei‐Malazy, Shahrzad Mohseni, et al.
Evidence-based Complementary and Alternative Medicine (2021) Vol. 2021, pp. 1-11
Open Access | Times Cited: 31
Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis
Ruwen Yang, Jingyu Shang, Yaru Zhou, et al.
Expert Review of Gastroenterology & Hepatology (2021) Vol. 15, Iss. 12, pp. 1401-1409
Closed Access | Times Cited: 25
Effects of antipsychotics on antioxidant defence system in patients with schizophrenia: A meta-analysis
Xue Xin Goh, Pek Yee Tang, Shiau Foon Tee
Psychiatry Research (2022) Vol. 309, pp. 114429-114429
Closed Access | Times Cited: 18
Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases
Han Ah Lee, Young Woon Chang, Pil Soo Sung, et al.
Clinical and Molecular Hepatology (2022) Vol. 28, Iss. 3, pp. 425-472
Open Access | Times Cited: 17
Roles and Mechanisms of Choline Metabolism in Nonalcoholic Fatty Liver Disease and Cancers
Xin Chen, Wenying Qiu, Xuqian Ma, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 5
Open Access | Times Cited: 3
The Benefit of Probiotics in Pediatric Nonalcoholic Fatty Liver Disease: A Meta-analysis of Randomized Control Trials
Νikolaos Gkiourtzis, Georgios Kalopitas, Andreas Vadarlis, et al.
Journal of Pediatric Gastroenterology and Nutrition (2022) Vol. 75, Iss. 3, pp. e31-e37
Closed Access | Times Cited: 15
Probiotics may be useful for drug-induced liver dysfunction in patients with depression – A secondary analysis of a randomized clinical trial
Oliwia Gawlik-Kotelnicka, Jacek Burzyński, Jakub Rogalski, et al.
Clinical Nutrition ESPEN (2024) Vol. 63, pp. 604-614
Open Access | Times Cited: 2
The effects of probiotic supplementation and exercise training on liver enzymes and cardiometabolic markers in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized clinical trials
Fatemeh Kazeminasab, Maryam Miraghajani, Khatereh Mokhtari, et al.
Nutrition & Metabolism (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Nutritional Approach Targeting Gut Microbiota in NAFLD—To Date
Małgorzata Moszak, Monika Szulińska, Marta Walczak‐Gałęzewska, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 4, pp. 1616-1616
Open Access | Times Cited: 16
Probiotics for the improvement of metabolic profiles in patients with metabolic-associated fatty liver disease: A systematic review and meta-analysis of randomized controlled trials
Qiuhong Wang, Ze Wang, Boxian Pang, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 11
The effect of heat‐killed Lactobacillus brevis SBL88 on improving selective hepatic insulin resistance in non‐alcoholic fatty liver disease mice without altering the gut microbiota
Hidemi Hayashi, Koji Sawada, Hiroki Tanaka, et al.
Journal of Gastroenterology and Hepatology (2023) Vol. 38, Iss. 10, pp. 1847-1854
Open Access | Times Cited: 6
Probiotics as a Treatment for “Metabolic Depression”? A Rationale for Future Studies
Oliwia Gawlik-Kotelnicka, Dominik Strzelecki
Pharmaceuticals (2021) Vol. 14, Iss. 4, pp. 384-384
Open Access | Times Cited: 15
Over-feeding the gut microbiome: A scoping review on health implications and therapeutic perspectives
Monica Barone, Federica D’Amico, Marco Fabbrini, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 41, pp. 7041-7064
Open Access | Times Cited: 14
New Developments in Microbiome in Alcohol-Associated and Nonalcoholic Fatty Liver Disease
Phillipp Hartmann, Bernd Schnabl
Seminars in Liver Disease (2021) Vol. 41, Iss. 01, pp. 087-102
Open Access | Times Cited: 13
Oral Administration of Recombinant Lactoferrin-Expressing Probiotics Ameliorates Diet-Induced Lipid Accumulation and Inflammation in Non-Alcoholic Fatty Liver Disease in Mice
Zhen‐Shu Liu, Peilin Li, Yu-We Ku, et al.
Microorganisms (2022) Vol. 10, Iss. 11, pp. 2215-2215
Open Access | Times Cited: 9
Individuals with Metabolic Syndrome Show Altered Fecal Lipidomic Profiles with No Signs of Intestinal Inflammation or Increased Intestinal Permeability
Mia J. Coleman, Luis M. Espino, Hernan Lebensohn, et al.
Metabolites (2022) Vol. 12, Iss. 5, pp. 431-431
Open Access | Times Cited: 8
Bifidobacterium lactis Probio‐M8 prevents nonalcoholic fatty liver disease in high‐fat diet‐fed rats: The potential role in modulating gut microbiota
Wen Fan, Kairui Tang, Yuanjun Deng, et al.
Food Bioengineering (2024) Vol. 3, Iss. 1, pp. 29-40
Open Access | Times Cited: 1
Lactiplantibacillus plantarum ZDY2013 Inhibits the Development of Non-Alcoholic Fatty Liver Disease by Regulating the Intestinal Microbiota and Modulating the PI3K/Akt Pathway
Qiang Teng, Huihui Lv, Lingling Peng, et al.
Nutrients (2024) Vol. 16, Iss. 7, pp. 958-958
Open Access | Times Cited: 1
Common Drug Pipelines for the Treatment of Diabetic Nephropathy and Hepatopathy: Can We Kill Two Birds with One Stone?
Yoshio Sumida, Masashi Yoneda, Hidenori Toyoda, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 4939-4939
Open Access | Times Cited: 12
Probiotics as a Treatment for “Metabolic Depression”? A Rationale for Future Studies
Oliwia Gawlik-Kotelnicka, Dominik Strzelecki
(2021)
Open Access | Times Cited: 8

Scroll to top